-
Insulin icodec, sold
under the
brand name Awiqli, is a
medication used for the
treatment of
diabetes to
improve glycemic control. It is an ultralong-acting...
-
Insulin icodec/semaglutide is an
experimental fixed-dose
combination of
insulin icodec and
semaglutide in
development for type 2
diabetes by Novo Nordisk...
-
second wave of
insulin analogues,
which include insulin degludec and
insulin icodec,
started in the mid-2010s.
Insulin analogues are
recombinant proteins that...
-
authorization for
insulin icodec. Subsequently,
insulin icodec was
approved for
medical use in the
European Union in May 2024.
Insulin icodec is
currently marketed...
- insulin‡ ultra-long-acting
Insulin degludec# (+insulin aspart, +liraglutide)
Insulin icodec† (+semaglutide)
inhalable Exubera‡
Afrezza Oral
Insulin tregopil†...
- insulin‡ ultra-long-acting
Insulin degludec# (+insulin aspart, +liraglutide)
Insulin icodec† (+semaglutide)
inhalable Exubera‡
Afrezza Oral
Insulin tregopil†...
- insulin‡ ultra-long-acting
Insulin degludec# (+insulin aspart, +liraglutide)
Insulin icodec† (+semaglutide)
inhalable Exubera‡
Afrezza Oral
Insulin tregopil†...
-
glargine A10AE05
Insulin detemir A10AE06
Insulin degludec A10AE07
Insulin icodec A10AE30
Combinations A10AE54
Insulin glargine and
lixisenatide A10AE56 Insulin...
- insulin‡ ultra-long-acting
Insulin degludec# (+insulin aspart, +liraglutide)
Insulin icodec† (+semaglutide)
inhalable Exubera‡
Afrezza Oral
Insulin tregopil†...
- insulin‡ ultra-long-acting
Insulin degludec# (+insulin aspart, +liraglutide)
Insulin icodec† (+semaglutide)
inhalable Exubera‡
Afrezza Oral
Insulin tregopil†...
